Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma

BACKGROUND: Concurrent chemoradiotherapy (CCRT) with tri-weekly high-dose cisplatin (HDC) is considered the standard regimen. However, due to significant toxicity, various weekly low-dose schedules have been increasingly used. We investigated the tolerability and survival of patients with head and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinohara, Shogo, Takebayashi, Shinji, Hamaguchi, Kiyomi, Michida, Tetsuhiko, Tobe, Yota, Ikenaga, Tadashi, Yasumoto, Mami, Hamamoto, Ayami, Imagumbai, Toshiyuki, Mitsuyoshi, Takamasa, Ashida, Ryo, Iwai, Takahiro, Okabayashi, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493312/
https://www.ncbi.nlm.nih.gov/pubmed/34629923
http://dx.doi.org/10.1177/11795549211048417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493312/
https://www.ncbi.nlm.nih.gov/pubmed/34629923
http://dx.doi.org/10.1177/11795549211048417

Ejemplares similares